Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) CEO Acquires $19,974.24 in Stock
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) CEO Talat Imran bought 10,296 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were purchased at an average price of $1.94 per share, with a total value of $19,974.24. Following the acquisition, the chief executive officer now directly owns 494,751 […]
More Stories
30-Year Fixed-Rate Mortgage Rate Hits 7.4 percent
By Naveen Athrappully The average weekly rate on a 30-year fixed-rate mortgage hit 7.4 percent, according to a Oct. 8...
US Issues Security Alert to Citizens in Middle East After Houthis Attack Saudi Arabia
By Aldgra Fredly The United States warned American citizens in the Middle East to remain vigilant on Thursday after Yemen’s...
Americans’ Incomes, Net Worth Climbed in Post-Pandemic Years: Federal Reserve
By Andrew Moran Americans’ incomes and net worth rose in the years after the pandemic, the Federal Reserve said in...
Judge Bars Deportation of Illegal Immigrant Shot by ICE in New York
By Aldgra Fredly A federal judge barred the Trump administration from deporting a Dominican immigrant who was shot by a...
‘It’s Time for Ukraine to Get a New President,’ Trump Says
By Timothy Frudd U.S. President Donald Trump suggested on Oct. 10 that Ukraine needs a new leader, one day after...
UAE Prosecutor Says Flydubai Co-Pilot Drifted Toward Extremism While in Australia
By Aldgra Fredly The co-pilot who allegedly attempted to hijack a Flydubai flight on Sept. 30 drifted toward extremism and...